FDA Inspection
Rex Garn Mabey Jr., M.D.Rex Garn Mabey Jr., M.D. – FDA Inspection, Nov 5, 2024
Record Details
This FDA Inspection record concerns Rex Garn Mabey Jr., M.D., with an inspection on November 5, 2024, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 2f169871-e16e-4ad4-806e-c86fa9494d0e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1253858
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rex Garn Mabey Jr., M.D.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 29, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 20, 2017 | Not classified | San Francisco District Office | |
| June 9, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 19, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 9, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Rex Garn Mabey Jr., M.D.
- FDA Inspection 1157839 - 2021-11-29
- FDA Inspection 1033969 - 2017-10-20
- FDA Inspection 1017040 - 2017-06-09
- FDA Inspection 806882 - 2012-10-19
- FDA Inspection 579688 - 2009-06-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.